Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Guardant Health stock | $124.12
Learn how to easily invest in Guardant Health stock.
Guardant Health, Inc is a diagnostics & research business based in the US. Guardant Health shares (GH) are listed on the NASDAQ and all prices are listed in US Dollars. Guardant Health employs 864 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Guardant Health
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – GH – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Guardant Health stock price (NASDAQ: GH)Use our graph to track the performance of GH stocks over time.
Guardant Health shares at a glance
|Latest market close||$124.12|
|52-week range||$77.69 - $180.83|
|50-day moving average||$120.27|
|200-day moving average||$139.42|
|Wall St. target price||$171.42|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-1.28|
Buy Guardant Health shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Guardant Health stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Guardant Health price performance over time
|1 week (2021-07-21)||N/A|
|1 month (2021-07-01)||-2.15%|
|3 months (2021-04-30)||-21.93%|
|6 months (2021-01-28)||N/A|
|1 year (2020-07-28)||N/A|
|2 years (2019-07-28)||N/A|
|3 years (2018-07-28)||N/A|
|5 years (2016-07-28)||N/A|
Guardant Health financials
|Revenue TTM||$297.9 million|
|Gross profit TTM||$194.2 million|
|Return on assets TTM||-12.07%|
|Return on equity TTM||-37.05%|
|Market capitalisation||$11.1 billion|
TTM: trailing 12 months
Shorting Guardant Health shares
There are currently 3.4 million Guardant Health shares held short by investors – that's known as Guardant Health's "short interest". This figure is 12.7% down from 3.9 million last month.
There are a few different ways that this level of interest in shorting Guardant Health shares can be evaluated.
Guardant Health's "short interest ratio" (SIR)
Guardant Health's "short interest ratio" (SIR) is the quantity of Guardant Health shares currently shorted divided by the average quantity of Guardant Health shares traded daily (recently around 975059.65909091). Guardant Health's SIR currently stands at 3.52. In other words for every 100,000 Guardant Health shares traded daily on the market, roughly 3520 shares are currently held short.
However Guardant Health's short interest can also be evaluated against the total number of Guardant Health shares, or, against the total number of tradable Guardant Health shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Guardant Health's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Guardant Health shares in existence, roughly 30 shares are currently held short) or 0.0356% of the tradable shares (for every 100,000 tradable Guardant Health shares, roughly 36 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Guardant Health.
Find out more about how you can short Guardant Health stock.
Guardant Health share dividends
We're not expecting Guardant Health to pay a dividend over the next 12 months.
Guardant Health share price volatility
Over the last 12 months, Guardant Health's shares have ranged in value from as little as $77.69 up to $180.83. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Guardant Health's is 0.5. This would suggest that Guardant Health's shares are less volatile than average (for this exchange).
Guardant Health overview
Guardant Health, Inc. , a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a clinical-genomic liquid biopsy dataset of advanced cancer patients. It is also developing tests from its LUNAR program for neoadjuvant and adjuvant treatment selection in early-stage cancer patients; LUNAR-2 test for the early detection of cancer in asymptomatic individuals eligible for cancer screening; and GuardantConnect, an integrated software-based solution for clinical and biopharmaceutical customers seeking to connect patients tested with the Guardant360 assay with actionable alterations with potentially relevant clinical trials. In addition, the company offers Guardant Reveal Test for residual disease and recurrence monitoring; Guardant360 tissue genotyping product; and Guardant-19 for use in the detection of the novel coronavirus. Further, it offers development services, including companion diagnostic development and regulatory approval, clinical trial referral, and liquid biopsy testing development and support services to biopharmaceutical companies and medical institutions. Daiichi Sankyo has collaboration with Guardant Health to develop Guardant360 CDx as a companion diagnostic for Enhertu in advanced metastatic non-small cell lung cancer.
Stocks similar to Guardant Health
Guardant Health in the news
Earnings Preview: Guardant Health (GH) Q2 Earnings Expected to Decline
ClearBridge All Cap Growth Strategy Portfolio Manager Commentary Q2 2021
Baron Funds Q2 2021 Andrew Peck Letter
Frequently asked questionsWhat percentage of Guardant Health is owned by insiders or institutions?
Currently 4.387% of Guardant Health shares are held by insiders and 87.743% by institutions. How many people work for Guardant Health?
Latest data suggests 864 work at Guardant Health. When does the fiscal year end for Guardant Health?
Guardant Health's fiscal year ends in December. Where is Guardant Health based?
Guardant Health's address is: 505 Penobscot Drive, Redwood City, CA, United States, 94063 What is Guardant Health's ISIN number?
Guardant Health's international securities identification number is: US40131M1099 What is Guardant Health's CUSIP number?
Guardant Health's Committee on Uniform Securities Identification Procedures number is: 40131M109
More guides on Finder
How to buy Argus Capital Corp (ARGU) stock when it goes public
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
How to buy RenovoRx (RNXT) stock when it goes public
Everything we know about the RenovoRx IPO, plus information on how to buy in.
How to buy Draganfly (DPRO) stock when it goes public
Everything we know about the Draganfly IPO, plus information on how to buy in.
How to buy Society Pass Incorporated (SOPA) stock when it goes public
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
How to buy Guardforce AI Co (GFAI) stock when it goes public
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
How to buy IsoPlexis Corporation (ISO) stock when it goes public
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
How to buy Marpai (MRAI) stock when it goes public
Everything we know about the Marpai IPO, plus information on how to buy in.
How to buy DoubleDown Interactive (DDI) stock when it goes public
Everything we know about the DoubleDown Interactive IPO, plus information on how to buy in.
How to buy Omniq Corp (OMQS) stock when it goes public
Everything we know about the Omniq Corp IPO, plus information on how to buy in.
How to buy Mechanical Technology (MKTYP) stock when it goes public
Everything we know about the Mechanical Technology IPO, plus information on how to buy in.
Ask an Expert